Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vertex Pharmaceuticals (VRTX) -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (540)	10/3/2001 8:30:45 PM
From: Miljenko Zuanic	Read Replies (1) \| Respond to of 1169

Wednesday October 3, 4:35 pm Eastern Time Press Release SOURCE: Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Announces the Appointment of Kenneth Boger as Senior Vice President and General Counsel <<In his extensive legal career, Mr. Boger has focused his practice in the areas of venture capital, startup and development-stage company representation, technology licensing and joint ventures, and mergers and acquisitions. >> One more B mouth to feed. I guess, 200K options are granted! Do they have free launch option for homeless in Boston? It will be more productive. Where is CFO? Maybe V. Sato is doing finance instead science? At least in finance she CAN NOT make to many mistakes! Niti hobotnica riba niti zudija cijadin! Miljenko